William Blair analyst Matt Phipps maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report) today. The company’s shares ...
Equities research analysts at William Blair cut their Q4 2025 earnings per share estimates for Tetra Tech in a research note ...
Shares of AI software company Palantir Technologies (PLTR) fell today, even after investment firm William Blair said that the ...
William Blair boosted their Q1 2026 earnings per share estimates for Acuity Brands in a research report issued on Thursday, ...
Walmart makes up a relatively small portion of Affirm’s business that the buy now, pay later company can make up elsewhere, ...
Fintel reports that on March 25, 2025, William Blair initiated coverage of Immunic (NasdaqGS:IMUX) with a Outperform ...
6d
Fintel on MSNWilliam Blair Initiates Coverage of StoneX Group (SNEX) with Outperform RecommendationFintel reports that on March 26, 2025, William Blair initiated coverage of StoneX Group (NasdaqGS:SNEX) with a Outperform ...
Palantir’s stock trades at a “frothy” multiple, but one former critic says his view on valuation has evolved somewhat.
Tesla shares fell more than 5% on Wednesday, ending the EV maker's blistering rebound out of a prolonged slump.
Lululemon stock fell 15% in afternoon trading after CEO Calvin McDonald said consumers are beginning to spend less in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results